The FcγR of humans and non-human primates and their interaction with IgG: Implications for induction of inflammation, resistance to infection and the use of therapeutic monoclonal antibodies

Current Topics in Microbiology and Immunology

Volumn 382, Issue , 2014, Pages 321-352

  Hogarth, P Mark ^a   Anania, Jessica C ^a   Wines, Bruce D ^a  

^a BURNET INSTITUTE   (Australia)

Author keywords

Broadly neutralising antibodies; Fc R; HIV; Inflammation; Macaque; Non human primates; Vaccine

Indexed keywords

CD16 ANTIGEN; FC GAMMA RECEPTOR I; FC GAMMA RECEPTOR II; FC GAMMA RECEPTOR IIIA; FC RECEPTOR; IMMUNOGLOBULIN G; IMMUNOGLOBULIN RECEPTOR; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG; FC RECEPTOR I; FC RECEPTOR II; FC RECEPTOR IIIA; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G4;

ANTIBODY RESPONSE; BINDING AFFINITY; DISEASE PREDISPOSITION; GENETIC POLYMORPHISM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN VERSUS ANIMAL COMPARISON; IMMUNOGENICITY; INFECTION RESISTANCE; INFLAMMATION; MACACA; MOLECULAR PATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; REVIEW; SEQUENCE ANALYSIS; STRUCTURE ANALYSIS; AMINO ACID SEQUENCE; ARTICLE; BINDING SITE; IMMUNITY; INFECTION RISK; PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ANIMALS; ANTIBODIES, MONOCLONAL; HUMANS; IMMUNOGLOBULIN G; INFECTION; INFLAMMATION; MACACA; POLYMORPHISM, GENETIC; RECEPTORS, IGG;

EID: 84958523199     PISSN: 0070217X     EISSN: 21969965     Source Type: Book Series    
DOI: 10.1007/978-3-319-07911-0_15     Document Type: Review

References (132)

1. Abboud N, Chow SK, Saylor C, Janda A, Ravetch JV, Scharff MD, Casadevall A (2010) A requirement for FcgammaR in antibody-mediated bacterial toxin neutralization. J Exp Med 207(11):2395-2405
2. Ackerman ME, Crispin M, Yu X, Baruah K, Boesch AW, Harvey DJ, Dugast AS, Heizen EL, Ercan A, Choi I, Streeck H, Nigrovic PA, Bailey-Kellogg C, Scanlan C, Alter G (2013a) Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity. J Clin Investig 123(5):2183-2192. doi:10.1172/JCI65708
3. Ackerman ME, Dugast AS, McAndrew EG, Tsoukas S, Licht AF, Irvine DJ, Alter G (2013b) Enhanced phagocytic activity of HIV-specific antibodies correlates with natural production of immunoglobulins with skewed affinity for FcgammaR2a and FcgammaR2b. J Virol 87(10):5468-5476. doi:10.1128/JVI.03403-12
4. Alizadeh BZ, Valdigem G, Coenen MJH, Zhernakova A, Franke B, Monsuur A, van Riel PLCM, Barrera P, Radstake TRDJ, Roep BO, Wijmenga C, Koeleman BPC (2007) Association analysis of functional variants of the FcgRIIa and FcgRIIIa genes with type 1 diabetes, celiac disease and rheumatoid arthritis. Hum Mol Genet 16(21):2552-2559. doi:10.1093/hmg/ddm194
5. Aloulou M, Ben Mkaddem S, Biarnes-Pelicot M, Boussetta T, Souchet H, Rossato E, Benhamou M, Crestani B, Zhu Z, Blank U, Launay P, Monteiro RC (2012) IgG1 and IVIg induce inhibitory ITAM signaling through FcgammaRIII controlling inflammatory responses. Blood 119(13):3084-3096. doi:10.1182/blood-2011-08- 376046
6. Alvarez RA, Hamlin RE, Monroe A, Moldt B, Hotta MT, Rodriguez Caprio G, Fierer DS, Simon V, Chen BK (2014) HIV-1 Vpu antagonism of tetherin inhibits antibody-dependent cellular cytotoxic responses by natural killer cells. J Virol. doi:10.1128/JVI.00449-14
7. Amigorena S (2002) Fc gamma receptors and cross-presentation in dendritic cells. J Exp Med 195(1):F1-F3
8. Autran B, Descours B, Avettand-Fenoel V, Rouzioux C (2011) Elite controllers as a model of functional cure. Current opinion in HIV and AIDS 6(3):181-187. doi:10.1097/COH. 0b013e328345a328
9. Barnes N, Gavin AL, Tan PS, Mottram P, Koentgen F, Hogarth PM (2002) FcgammaRI-deficient mice show multiple alterations to inflammatory and immune responses. Immunity 16(3):379-389
10. Barouch DH, Liu J, Peter L, Abbink P, Iampietro MJ, Cheung A, Alter G, Chung A, Dugast AS, Frahm N, McElrath MJ, Wenschuh H, Reimer U, Seaman MS, Pau MG, Weijtens M, Goudsmit J, Walsh SR, Dolin R, Baden LR (2013a) Characterization of humoral and cellular immune responses elicited by a recombinant adenovirus serotype 26 HIV-1 Env vaccine in healthy adults (IPCAVD 001). J Infect Dis 207(2):248-256. doi:10.1093/infdis/jis671
11. Barouch DH, Stephenson KE, Borducchi EN, Smith K, Stanley K, McNally AG, Liu J, Abbink P, Maxfield LF, Seaman MS, Dugast AS, Alter G, Ferguson M, Li W, Earl PL, Moss B, Giorgi EE, Szinger JJ, Eller LA, Billings EA, Rao M, Tovanabutra S, Sanders-Buell E, Weijtens M, Pau MG, Schuitemaker H, Robb ML, Kim JH, Korber BT, Michael NL (2013b) Protective efficacy of a global HIV-1 mosaic vaccine against heterologous SHIV challenges in rhesus monkeys. Cell 155(3):531-539. doi:10.1016/j.cell.2013.09.061
12. Bibeau F, Lopez-Crapez E, Di Fiore F, Thezenas S, Ychou M, Blanchard F, Lamy A, Penault- Llorca F, Frébourg T, Michel P, Sabourin J-C, Boissière-Michot F (2009) Impact of FcγRIIa- FcγRIIIa polymorphisms and KRAS mutations on the clinical outcome of patients with metastatic colorectal cancer treated with cetuximab plus irinotecan. J Clin Oncol 27(7):1122-1129. doi:10.1200/jco.2008.18.0463
13. Brouwer KC, Lal RB, Mirel LB, Yang C, Eijk AM, Ayisi J, Otieno J, Nahlen BL, Steketee R, Lal AA, Shi YP (2004) Polymorphism of Fc receptor IIa for IgG in infants is associated with susceptibility to perinatal HIV-1 infection. AIDS 18(8):1187-1194
14. Bruhns P, Iannascoli B, England P, Mancardi DA, Fernandez N, Jorieux S, Daeron M (2009) Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses. Blood 113(16):3716-3725
15. Burton DR, Woof JM (1992) Human antibody effector function. In: Frank JD (ed) Advances in immunology, vol 51. Academic Press, pp 1-84. doi:http://dx.doi.org/10.1016/S0065-2776(08) 60486-1
16. Cady CT, Powell MS, Harbeck RJ, Giclas PC, Murphy JR, Katial RK, Weber RW, Hogarth PM, Johnson S, Bonvini E, Koenig S, Cambier JC (2010) IgG antibodies produced during subcutaneous allergen immunotherapy mediate inhibition of basophil activation via a mechanism involving both FcgammaRIIA and FcgammaRIIB. Immunol Lett 130(1-2):57-65
17. Cady CT, Rice JS, Ott VL, Cambier JC (2008) Regulation of hematopoietic cell function by inhibitory immunoglobulin G receptors and their inositol lipid phosphatase effectors. Immunol Rev 224:44-57. doi:10.1111/j.1600-065X.2008. 00663.x
18. Cambier JC (2013) Autoimmunity risk alleles: hotspots in B cell regulatory signaling pathways. J Clin Investig 123(5):1928-1931. doi:10.1172/JCI69289
19. Cartron G, Dacheux L, Salles G, Solal-Celigny P, Bardos P, Colombat P, Watier H (2002) Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcγRIIIa gene. Blood 99(3):754-758. doi:10.1182/blood.V99.3.754
20. Cassard L, Jonsson F, Arnaud S, Daeron M (2012) Fcgamma receptors inhibit mouse and human basophil activation. J Immunol 189(6):2995-3006. doi:10.4049/jimmunol.1200968
21. Choi EI, Wang R, Peterson L, Letvin NL, Reimann KA (2008) Use of an anti-CD16 antibody for in vivo depletion of natural killer cells in rhesus macaques. Immunology 124(2):215-222. doi:10.1111/j.1365-2567.2007.02757.x
22. Chu SY, Horton HM, Pong E, Leung IW, Chen H, Nguyen DH, Bautista C, Muchhal US, Bernett MJ, Moore GL, Szymkowski DE, Desjarlais JR (2012) Reduction of total IgE by targeted coengagement of IgE B-cell receptor and FcgammaRIIb with Fc-engineered antibody. J Allergy Clin Immunol 129(4):1102-1115. doi:10.1016/j.jaci.2011.11.029
23. Chu SY, Yeter K, Kotha R, Pong E, Miranda Y, Phung S, Chen H, Lee SH, Leung I, Bonzon C, Desjarlais JR, Stohl W, Szymkowski DE (2013) Suppression of rheumatoid arthritis B cells by XmAb5871, an anti-CD19 antibody that coengages B cell antigen receptor and FcgammaRIIb inhibitory receptor. Arthritis Rheum. doi:10.1002/art.38334
24. Chung AW, Isitman G, Navis M, Kramski M, Center RJ, Kent SJ, Stratov I (2011) Immune escape from HIV-specific antibody-dependent cellular cytotoxicity (ADCC) pressure. Proc Natl Acad Sci USA 108(18):7505-7510. doi:10.1073/pnas. 1016048108
25. Clatworthy MR, Willcocks L, Urban B, Langhorne J, Williams TN, Peshu N, Watkins NA, Floto RA, Smith KG (2007) Systemic lupus erythematosus-associated defects in the inhibitory receptor FcgammaRIIb reduce susceptibility to malaria. Proc Natl Acad Sci USA 104(17):7169-7174. doi:10.1073/pnas.0608889104
26. Daeron M, Latour S, Malbec O, Espinosa E, Pina P, Pasmans S, Fridman WH (1995) The same tyrosine-based inhibition motif, in the intracytoplasmic domain of Fc gamma RIIB, regulates negatively BCR-, TCR-, and FcR-dependent cell activation. Immunity 3(5):635-646
27. Daeron M, Lesourne R (2006) Negative signaling in Fc receptor complexes. Adv Immunol 89:39-86
28. Davies AM, Rispens T, Ooijevaar-de Heer P, Gould HJ, Jefferis R, Aalberse RC, Sutton BJ (2014) Structural determinants of unique properties of human IgG4-Fc. J Mol Biol 426(3):630-644. doi:10.1016/j.jmb.2013.10.039
29. den Dunnen J, Vogelpoel LT, Wypych T, Muller FJ, de Boer L, Kuijpers TW, Zaat SA, Kapsenberg ML, de Jong EC (2012) IgG opsonization of bacteria promotes Th17 responses via synergy between TLRs and FcgammaRIIa in human dendritic cells. Blood 120(1):112-121. doi:10.1182/blood-2011-12-399931
30. Dijstelbloem HM, Scheepers RHM, Oost WW, Stegeman CA, Van Der Pol WL, Sluiter WJ, Kallenberg CGM, Van De Winkel JGJ, Tervaert JWC (1999) Fcc receptor polymorphisms in Wegener's granulomatosis: risk factors for disease relapse. Arthritis Rheum 42(9):1823-1827. doi:10.1002/1529-0131(199909)42:9\1823:AID- ANR5>3.0.CO;2-X
31. Domingo P, Muñiz-Diaz E, Baraldès MA, Arilla M, Barquet N, Pericas R, Juárez C, Madoz P, Vázquez G (2002) Associations between Fc gamma receptor IIA polymorphisms and the risk and prognosis of meningococcal disease. Am J Med 112 (1):19-25. doi:http://dx.doi.org/10. 1016/S0002-9343(01)01047-6
32. Doria-Rose NA, Schramm CA, Gorman J, Moore PL, Bhiman JN, Dekosky BJ, Ernandes MJ, Georgiev IS, Kim HJ, Pancera M, Staupe RP, Altae-Tran HR, Bailer RT, Crooks ET, Cupo A, Druz A, Garrett NJ, Hoi KH, Kong R, Louder MK, Longo NS, McKee K, Nonyane M, O'Dell S, Roark RS, Rudicell RS, Schmidt SD, Sheward DJ, Soto C, Wibmer CK, Yang Y, Zhang Z, Nisc Comparative S, Mullikin JC, Binley JM, Sanders RW, Wilson IA, Moore JP, Ward AB, Georgiou G, Williamson C, Abdool Karim SS, Morris L, Kwong PD, Shapiro L, Mascola JR (2014) Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies. Nature. doi:10.1038/ nature13036
33. Dugast AS, Tonelli A, Berger CT, Ackerman ME, Sciaranghella G, Liu Q, Sips M, Toth I, Piechocka-Trocha A, Ghebremichael M, Alter G (2011) Decreased Fc receptor expression on innate immune cells is associated with impaired antibody-mediated cellular phagocytic activity in chronically HIV-1 infected individuals. Virology 415(2):160-167. doi:10.1016/j. virol.2011.03.012
34. Duncan AR, Woof JM, Partridge LJ, Burton DR, Winter G (1988) Localization of the binding site for the human high-affinity Fc receptor on IgG. Nature 332(6164):563-564. doi:10.1038/ 332563a0
35. Ellery PJ, Tippett E, Chiu YL, Paukovics G, Cameron PU, Solomon A, Lewin SR, Gorry PR, Jaworowski A, Greene WC, Sonza S, Crowe SM (2007) The CD16 + monocyte subset is more permissive to infection and preferentially harbors HIV-1 in vivo. J Immunol 178(10):6581-6589
36. Ferrara C, Grau S, Jager C, Sondermann P, Brunker P, Waldhauer I, Hennig M, Ruf A, Rufer AC, Stihle M, Umana P, Benz J (2011) Unique carbohydrate- carbohydrate interactions are required for high affinity binding between FcgammaRIII and antibodies lacking core fucose. Proc Natl Acad Sci USA 108(31):12669-12674. doi:10.1073/pnas.1108455108
37. Fijen CA, Bredius RG, Kuijper EJ (1993) Polymorphism of IgG Fc receptors in meningococcal disease. Ann Intern Med 119(7 Pt 1):636
38. Forthal DN, Gabriel EE, Wang A, Landucci G, Phan TB (2012) Association of Fcgamma receptor IIIa genotype with the rate of HIV infection after gp120 vaccination. Blood 120(14):2836-2842. doi:10.1182/blood-2012-05-431361
39. Forthal DN, Landucci G, Bream J, Jacobson LP, Phan TB, Montoya B (2007) FcgammaRIIa genotype predicts progression of HIV infection. J Immunol 179(11):7916-7923
40. Forthal DN, Landucci G, Ding H, Kappes JC, Wang A, Thung I, Phan T (2011) IgG2 inhibits HIV-1 internalization by monocytes, and IgG subclass binding is affected by gp120 glycosylation. AIDS 25(17):2099-2104. doi:10.1097/QAD. 0b013e32834b64bd
41. Forthal DN, Landucci G, Phan TB, Becerra J (2005) Interactions between natural killer cells and antibody Fc result in enhanced antibody neutralization of human immunodeficiency virus type 1. J Virol 79(4):2042-2049. doi:10.1128/JVI.79.4.2042-2049.2005
42. Forthal DN, Moog C (2009) Fc receptor-mediated antiviral antibodies. Curr Opin HIV AIDS 4(5):388-393. doi:10.1097/COH.0b013e32832f0a89
43. French MA, Center RJ, Wilson KM, Fleyfel I, Fernandez S, Schorcht A, Stratov I, Kramski M, Kent SJ, Kelleher AD (2013) Isotype-switched immunoglobulin G antibodies to HIV Gag proteins may provide alternative or additional immune responses to 'protective' human leukocyte antigen-B alleles in HIV controllers. AIDS 27(4):519-528. doi:10.1097/QAD. 0b013e32835cb720
44. French MA, Tanaskovic S, Law MG, Lim A, Fernandez S, Ward LD, Kelleher AD, Emery S (2010) Vaccine-induced IgG2 anti-HIV p24 is associated with control of HIV in patients with a 'high-affinity' FcgammaRIIa genotype. AIDS 24(13):1983-1990
45. Gavin AL, Barnes N, Dijstelbloem HM, Hogarth PM (1998a) Identification of the mouse IgG3 receptor: implications for antibody effector function at the interface between innate and adaptive immunity. J Immunol 160(1):20-23
46. Gavin AL, Tan PS, Hogarth PM (1998b) Gain-of-function mutations in FcgammaRI of NOD mice: implications for the evolution of the Ig superfamily. EMBO J 17(14):3850-3857
47. Giha HA, Nasr A, Iriemenam NC, Troye-Blomberg M, Berzins K, ElGhazali G (2012) Lack of significant influence for FcgammaRIIa-RH131 or hemoglobin AA/AS polymorphisms on immunity and susceptibility to uncomplicated malaria and existence of marked linkage between the two polymorphisms in Daraweesh. Microbes Infect 14(6):537-544. doi:10.1016/ j.micinf.2012.01.003
48. Gomez-Roman VR, Patterson LJ, Venzon D, Liewehr D, Aldrich K, Florese R, Robert-Guroff M (2005) Vaccine-elicited antibodies mediate antibody-dependent cellular cytotoxicity correlated with significantly reduced acute viremia in rhesus macaques challenged with SIVmac251. J Immunol 174(4):2185-2189
49. Gupta S, Gach JS, Becerra JC, Phan TB, Pudney J, Moldoveanu Z, Joseph SB, Landucci G, Supnet MJ, Ping LH, Corti D, Moldt B, Hel Z, Lanzavecchia A, Ruprecht RM, Burton DR, Mestecky J, Anderson DJ, Forthal DN (2013) The neonatal Fc receptor (FcRn) enhances human immunodeficiency virus type 1 (HIV-1) transcytosis across epithelial cells. PLoS Pathog 9(11):e1003776. doi:10.1371/journal.ppat.1003776
50. Harley JB, Alarcon-Riquelme ME, Criswell LA, Jacob CO, Kimberly RP, Moser KL, Tsao BP, Vyse TJ, Langefeld CD (2008) Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet 40 (2):204-210. doi:http://www.nature. com/ng/journal/v40/n2/suppinfo/ng.81-S1.Html
51. Haynes BF, Gilbert PB, McElrath MJ, Zolla-Pazner S, Tomaras GD, Alam SM, Evans DT, Montefiori DC, Karnasuta C, Sutthent R, Liao HX, DeVico AL, Lewis GK, Williams C, Pinter A, Fong Y, Janes H, DeCamp A, Huang Y, Rao M, Billings E, Karasavvas N, Robb ML, Ngauy V, de Souza MS, Paris R, Ferrari G, Bailer RT, Soderberg KA, Andrews C, Berman PW, Frahm N, De Rosa SC, Alpert MD, Yates NL, Shen X, Koup RA, Pitisuttithum P, Kaewkungwal J, Nitayaphan S, Rerks-Ngarm S, Michael NL, Kim JH (2012) Immunecorrelates analysis of an HIV-1 vaccine efficacy trial. New Engl J Med 366(14):1275-1286. doi:10.1056/NEJMoa1113425
52. Hessell AJ, Hangartner L, Hunter M, Havenith CE, Beurskens FJ, Bakker JM, Lanigan CM, Landucci G, Forthal DN, Parren PW, Marx PA, Burton DR (2007) Fc receptor but not complement binding is important in antibody protection against HIV. Nature 449(7158):101-104
53. Hessell AJ, Rakasz EG, Poignard P, Hangartner L, Landucci G, Forthal DN, Koff WC, Watkins DI, Burton DR (2009) Broadly neutralizing human anti-HIV antibody 2G12 is effective in protection against mucosal SHIV challenge even at low serum neutralizing titers. PLoS Pathog 5(5):e1000433
54. Hibbs ML, Bonadonna L, Scott BM, McKenzie IF, Hogarth PM (1988) Molecular cloning of a human immunoglobulin G Fc receptor. Proc Natl Acad Sci USA 85(7):2240-2244
55. Hogarth PM (2002) Fc receptors are major mediators of antibody based inflammation in autoimmunity. Curr Opin Immunol 14(6):798-802
56. Hogarth PM, Pietersz GA (2012) Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond. Nat Rev Drug Discov 11(4):311-331. doi:10.1038/nrd2909
57. Holl V, Hemmerter S, Burrer R, Schmidt S, Bohbot A, Aubertin AM, Moog C (2004) Involvement of Fc gamma RI (CD64) in the mechanism of HIV-1 inhibition by polyclonal IgG purified from infected patients in cultured monocyte-derived macrophages. J Immunol 173(10):6274-6283
58. Horton HM, Chu SY, Ortiz EC, Pong E, Cemerski S, Leung IW, Jacob N, Zalevsky J, Desjarlais JR, Stohl W, Szymkowski DE (2011) Antibody-mediated coengagement of FcgammaRIIb and B cell receptor complex suppresses humoral immunity in systemic lupus erythematosus. J Immunol 186(7):4223-4233. doi:10.4049/jimmunol.1003412
59. Hulett MD, Brinkworth RI, McKenzie IF, Hogarth PM (1999) Fine structure analysis of interaction of FcepsilonRI with IgE. J Biol Chem 274(19):13345-13352
60. Hulett MD, Hogarth PM (1994) Molecular basis of Fc receptor function. Adv Immunol 57:1-127
61. Hulett MD, Witort E, Brinkworth RI, McKenzie IF, Hogarth PM (1995) Multiple regions of human Fc gamma RII (CD32) contribute to the binding of IgG. J Biol Chem 270(36):21188-21194
62. Ierino FL, Powell MS, McKenzie IF, Hogarth PM (1993) Recombinant soluble human Fc gamma RII: production, characterization, and inhibition of the Arthus reaction. J Exp Med 178(5):1617-1628
63. International HIVCS, Pereyra F, Jia X, McLaren PJ, Telenti A, de Bakker PI, Walker BD, Ripke S, Brumme CJ, Pulit SL, Carrington M, Kadie CM, Carlson JM, Heckerman D, Graham RR, Plenge RM, Deeks SG, Gianniny L, Crawford G, Sullivan J, Gonzalez E, Davies L, Camargo A, Moore JM, Beattie N, Gupta S, Crenshaw A, Burtt NP, Guiducci C, Gupta N, Gao X, Qi Y, Yuki Y, Piechocka-Trocha A, Cutrell E, Rosenberg R, Moss KL, Lemay P, O'Leary J, Schaefer T, Verma P, Toth I, Block B, Baker B, Rothchild A, Lian J, Proudfoot J, Alvino DM, Vine S, Addo MM, Allen TM, Altfeld M, Henn MR, Le Gall S, Streeck H, Haas DW, Kuritzkes DR, Robbins GK, Shafer RW, Gulick RM, Shikuma CM, Haubrich R, Riddler S, Sax PE, Daar ES, Ribaudo HJ, Agan B, Agarwal S, Ahern RL, Allen BL, Altidor S, Altschuler EL, Ambardar S, Anastos K, Anderson B, Anderson V, Andrady U, Antoniskis D, Bangsberg D, Barbaro D, Barrie W, Bartczak J, Barton S, Basden P, Basgoz N, Bazner S, Bellos NC, Benson AM, Berger J, Bernard NF, Bernard AM, Birch C, Bodner SJ, Bolan RK, Boudreaux ET, Bradley M, Braun JF, Brndjar JE, Brown SJ, Brown K, Brown ST, Burack J, Bush LM, Cafaro V, Campbell O, Campbell J, Carlson RH, Carmichael JK, Casey KK, Cavacuiti C, Celestin G, Chambers ST, Chez N, Chirch LM, Cimoch PJ, Cohen D, Cohn LE, Conway B, Cooper DA, Cornelson B, Cox DT, Cristofano MV, Cuchural G, Jr, Czartoski JL, Dahman JM, Daly JS, Davis BT, Davis K, Davod SM, DeJesus E, Dietz CA, Dunham E, Dunn ME, Ellerin TB, Eron JJ, Fangman JJ, Farel CE, Ferlazzo H, Fidler S, Fleenor-Ford A, Frankel R, Freedberg KA, French NK, Fuchs JD, Fuller JD, Gaberman J, Gallant JE, Gandhi RT, Garcia E, Garmon D, Gathe JC, Jr, Gaultier CR, Gebre W, Gilman FD, Gilson I, Goepfert PA, Gottlieb MS, Goulston C, Groger RK, Gurley TD, Haber S, Hardwicke R, Hardy WD, Harrigan PR, Hawkins TN, Heath S, Hecht FM, Henry WK, Hladek M, Hoffman RP, Horton JM, Hsu RK, Huhn GD, Hunt P, Hupert MJ, Illeman ML, Jaeger H, Jellinger RM, John M, Johnson JA, Johnson KL, Johnson H, Johnson K, Joly J, Jordan WC, Kauffman CA, Khanlou H, Killian RK, Kim AY, Kim DD, Kinder CA, Kirchner JT, Kogelman L, Kojic EM, Korthuis PT, Kurisu W, Kwon DS, LaMar M, Lampiris H, Lanzafame M, Lederman MM, Lee DM, Lee JM, Lee MJ, Lee ET, Lemoine J, Levy JA, Llibre JM, Liguori MA, Little SJ, Liu AY, Lopez AJ, Loutfy MR, Loy D, Mohammed DY, Man A, Mansour MK, Marconi VC, Markowitz M, Marques R, Martin JN, Martin HL, Jr, Mayer KH, McElrath MJ, McGhee TA, McGovern BH, McGowan K, McIntyre D, McLeod GX, Menezes P, Mesa G, Metroka CE, Meyer-Olson D, Miller AO, Montgomery K, Mounzer KC, Nagami EH, Nagin I, Nahass RG, Nelson MO, Nielsen C, Norene DL, O'Connor DH, Ojikutu BO, Okulicz J, Oladehin OO, Oldfield EC, 3rd, Olender SA, Ostrowski M, Owen WF, Jr, Pae E, Parsonnet J, Pavlatos AM, Perlmutter AM, Pierce MN, Pincus JM, Pisani L, Price LJ, Proia L, Prokesch RC, Pujet HC, Ramgopal M, Rathod A, Rausch M, Ravishankar J, Rhame FS, Richards CS, Richman DD, Rodes B, Rodriguez M, Rose RC, 3rd, Rosenberg ES, Rosenthal D, Ross PE, Rubin DS, Rumbaugh E, Saenz L, Salvaggio MR, Sanchez WC, Sanjana VM, Santiago S, Schmidt W, Schuitemaker H, Sestak PM, Shalit P, Shay W, Shirvani VN, Silebi VI, Sizemore JM, Jr, Skolnik PR, Sokol-Anderson M, Sosman JM, Stabile P, Stapleton JT, Starrett S, Stein F, Stellbrink HJ, Sterman FL, Stone VE, Stone DR, Tambussi G, Taplitz RA, Tedaldi EM, Telenti A, Theisen W, Torres R, Tosiello L, Tremblay C, Tribble MA, Trinh PD, Tsao A, Ueda P, Vaccaro A, Valadas E, Vanig TJ, Vecino I, Vega VM, Veikley W, Wade BH, Walworth C, Wanidworanun C, Ward DJ, Warner DA, Weber RD, Webster D, Weis S, Wheeler DA, White DJ, Wilkins E, Winston A, Wlodaver CG, van't Wout A, Wright DP, Yang OO, Yurdin DL, Zabukovic BW, Zachary KC, Zeeman B, Zhao M (2010) The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science 330(6010):1551-1557. doi:10.1126/science.1195271
64. Isitman G, Stratov I, Kent SJ (2012) Antibody-dependent cellular cytotoxicity and NK cell-driven immune escape in HIV infection: implications for HIV vaccine development. Adv Virol 2012:637208. doi:10.1155/2012/637208
65. Jacobsen FW, Padaki R, Morris AE, Aldrich TL, Armitage RJ, Allen MJ, Lavallee JC, Arora T (2011) Molecular and functional characterization of cynomolgus monkey IgG subclasses. J Immunol 186:341-349
66. Jonsson F, Daeron M (2012) Mast cells and company. Front Immunol 3:16. doi:10.3389/fimmu. 2012.00016
67. Karassa FB, Trikalinos TA, Ioannidis JP, Fcgamma R-SLEM-AI (2002) Role of the Fcgamma receptor IIa polymorphism in susceptibility to systemic lupus erythematosus and lupus nephritis: a meta-analysis. Arthritis Rheum 46(6):1563-1571. doi:10.1002/art.10306
68. Kedzierska K, Azzam R, Ellery P, Mak J, Jaworowski A, Crowe SM (2003) Defective phagocytosis by human monocyte/macrophages following HIV-1 infection: underlying mechanisms and modulation by adjunctive cytokine therapy. J Clin Virol 26(2):247-263
69. Klein JS, Bjorkman PJ (2010) Few and far between: how HIV may be evading antibody avidity. PLoS Pathog 6(5):e1000908
70. Koene HR, Kleijer M, Swaak AJ, Sullivan KE, Bijl M, Petri MA, Kallenberg CG, Roos D, von dem Borne AE, de Haas M (1998) The Fc gammaRIIIA-158F allele is a risk factor for systemic lupus erythematosus. Arthritis Rheum 41(10):1813-1818. doi:10.1002/ 1529-0131(199810)41:10\1813:AID-ART13>3.0. CO;2-6
71. Kramski M, Schorcht A, Johnston AP, Lichtfuss GF, Jegaskanda S, De Rose R, Stratov I, Kelleher AD, French MA, Center RJ, Jaworowski A, Kent SJ (2012) Role of monocytes in mediating HIV-specific antibody-dependent cellular cytotoxicity. J Immunol Methods 384(1-2):51-61. doi:10.1016/j.jim.2012.07.006
72. Lambotte O, Pollara J, Boufassa F, Moog C, Venet A, Haynes BF, Delfraissy JF, Saez-Cirion A, Ferrari G (2013) High antibody-dependent cellular cytotoxicity responses are correlated with strong CD8 T cell viral suppressive activity but not with B57 status in HIV-1 elite controllers. PLoS ONE 8(9):e74855. doi:10.1371/journal.pone.0074855
73. Leeansyah E, Wines BD, Crowe SM, Jaworowski A (2007) The mechanism underlying defective Fcgamma receptor-mediated phagocytosis by HIV-1-infected human monocyte-derived macrophages. J Immunol 178(2):1096-1104
74. Lessard CJ, Li H, Adrianto I, Ice JA, Rasmussen A, Grundahl KM, Kelly JA, Dozmorov MG, Miceli-Richard C, Bowman S, Lester S, Eriksson P, Eloranta ML, Brun JG, Goransson LG, Harboe E, Guthridge JM, Kaufman KM, Kvarnstrom M, Jazebi H, Cunninghame Graham DS, Grandits ME, Nazmul-Hossain AN, Patel K, Adler AJ, Maier-Moore JS, Farris AD, Brennan MT, Lessard JA, Chodosh J, Gopalakrishnan R, Hefner KS, Houston GD, Huang AJ, Hughes PJ, Lewis DM, Radfar L, Rohrer MD, Stone DU, Wren JD, Vyse TJ, Gaffney PM, James JA, Omdal R, Wahren-Herlenius M, Illei GG, Witte T, Jonsson R, Rischmueller M, Ronnblom L, Nordmark G, Ng WF, Registry UKPSsS, Mariette X, Anaya JM, Rhodus NL, Segal BM, Scofield RH, Montgomery CG, Harley JB, SivilsKL (2013) Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjogren's syndrome. Nat Genet 45(11):1284-1292. doi:10.1038/ng.2792
75. Li X, Wu J, Carter RH, Edberg JC, Su K, Cooper GS, Kimberly RP (2003) A novel polymorphism in the Fcc receptor IIB (CD32B) transmembrane region alters receptor signaling. Arthritis Rheum 48(11):3242-3252. doi:10.1002/art.11313
76. Lichterfeld M, Yu XG (2012) The emerging role of leukocyte immunoglobulin-like receptors (LILRs) in HIV-1 infection. J Leukoc Biol 91(1):27-33. doi:10.1189/jlb.0811442
77. Lichtfuss GF, Cheng WJ, Farsakoglu Y, Paukovics G, Rajasuriar R, Velayudham P, Kramski M, Hearps AC, Cameron PU, Lewin SR, Crowe SM, Jaworowski A (2012) Virologically suppressed HIV patients show activation of NK cells and persistent innate immune activation. J Immunol 189(3):1491-1499. doi:10.4049/jimmunol.1200458
78. Lu J, Ellsworth JL, Hamacher N, Oak SW, Sun PD (2011) Crystal structure of Fc receptor I and its implication in high affinity c-immunoglobulin binding. J Biol Chem 286(47):40608-40613
79. Ludlow LE, Zhou J, Tippett E, Cheng WJ, Hasang W, Rogerson SJ, Jaworowski A (2012) HIV-1 inhibits phagocytosis and inflammatory cytokine responses of human monocyte-derived macrophages to P. falciparum infected erythrocytes. PLoS ONE 7(2):e32102. doi:10.1371/ journal.pone.0032102
80. Maenaka K, van der Merwe PA, Stuart DI, Jones EY, Sondermann P (2001) The human low affinity Fcc receptors IIa, IIb, and III Bind IgG with fast kinetics and distinct thermodynamic properties. J Biol Chem 276(48):44898-44904. doi:10.1074/jbc.M106819200
81. Mahan JD, Hebert LA, McAllister C, Birmingham DJ, Shen XP, Cosio FG, Brandt J (1993) Platelet involvement in experimental immune complex-mediated glomerulonephritis in the nonhuman primate. Kidney Int 44(4):716-725
82. Maiga B, Dolo A, Touré O, Dara V, Tapily A, Campino S, Sepulveda N, Corran P, Rockett K, Clark TG, Troye Blomberg M, Doumbo OK (2014) Fc gamma receptor IIa-H131R polymorphism and malaria susceptibility in sympatric ethnic groups, Fulani and Dogon of Mali. Scand J Immunol 79(1):43-50. doi:10.1111/sji.12122
83. Manuzak JA, Dillon SM, Lee EJ, Dong ZM, Hecht DK, Wilson CC (2013) Increased Escherichia coli-induced interleukin-23 production by CD16 + monocytes correlates with systemic immune activation in untreated HIV-1-infected individuals. J Virol 87(24):13252-13262. doi:10.1128/JVI.01767-13
84. Maxwell KF, Powell MS, Hulett MD, Barton PA, McKenzie IF, Garrett TP, Hogarth PM (1999) Crystal structure of the human leukocyte Fc receptor, Fc gammaRIIa. Nat Struct Biol 6(5):437-442
85. McGovern DPB, Gardet A, Törkvist L, Goyette P, Essers J, Taylor KD, Neale BM, Ong RTH, Lagacé C, Li C, Green T, Stevens CR, Beauchamp C, Fleshner PR, Carlson M, D'Amato M, Halfvarson J, Hibberd ML, Lördal M, Padyukov L, Andriulli A, Colombo E, Latiano A, Palmieri O, Bernard E-J, Deslandres C, Hommes DW, de Jong DJ, Stokkers PC, Weersma RK, The NIDDKIBDGC, Sharma Y, Silverberg M, Cho JH, Wu J, Roeder K, Brant SR, Schumm LP, Duerr RH, Dubinsky MC, Glazer NL, Haritunians T, Ippoliti A, Melmed GY, Siscovick DS, Vasiliauskas EA, Targan SR, Annese V, Wijmenga C, Pettersson S, Rotter JI, Xavier RJ, Daly MJ, Rioux JD, Seielstad M (2010) Genome-wide association identifies multiple ulcerative colitis susceptibility loci. Nat Genet 42(4):332-337
86. Means TK, Latz E, Hayashi F, Murali MR, Golenbock DT, Luster AD (2005) Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. J Clin Investig 115(2):407-417. doi:10.1172/JCI23025
87. Metzger H (1992) Transmembrane signaling: the joy of aggregation. J Immunol 149(5):1477-1487
88. Meziani R, Yamada R, Takahashi M, Ohigashi K, Morinobu A, Terao C, Hiratani H, Ohmura K, Yamaguchi M, Nomura T, Vasilescu A, Kokubo M, Renault V, Hirosawa K, Ratanajaraya C, Heath S, Mimori T, Sakaguchi S, Lathrop M, Melchers I, Kumagai S, Matsuda F (2012) A trans-ethnic genetic study of rheumatoid arthritis identified FCGR2A as a candidate common risk factor in Japanese and European populations. Mod Rheumatol 22(1):52-58. doi:10.1007/ s10165-011-0467-y
89. Mihai S, Nimmerjahn F (2013) The role of Fc receptors and complement in autoimmunity. Autoimmun Rev 12(6):657-660. doi:10.1016/j.autrev.2012.10.008
90. Mizushima T, Yagi H, Takemoto E, Shibata-Koyama M, Isoda Y, Iida S, Masuda K, Satoh M, Kato K (2011) Structural basis for improved efficacy of therapeutic antibodies on defucosylation of their Fc glycans. Genes Cells 16(11):1071-1080. doi:10.1111/j. 1365-2443.2011.01552.x
91. Moldt B, Shibata-Koyama M, Rakasz EG, Schultz N, Kanda Y, Dunlop DC, Finstad SL, Jin C, Landucci G, Alpert MD, Dugast AS, Parren PW, Nimmerjahn F, Evans DT, Alter G, Forthal DN, Schmitz JE, Iida S, Poignard P, Watkins DI, Hessell AJ, Burton DR (2012) A nonfucosylated variant of the anti-HIV-1 monoclonal antibody b12 has enhanced FcgammaRIIIa-mediated antiviral activity in vitro but does not improve protection against mucosal SHIV challenge in macaques. J Virol 86(11):6189-6196. doi:10.1128/JVI.00491-12
92. Moog C, Dereuddre-Bosquet N, Teillaud JL, Biedma ME, Holl V, Van Ham G, Heyndrickx L, Van Dorsselaer A, Katinger D, Vcelar B, Zolla-Pazner S, Mangeot I, Kelly C, Shattock RJ, Le Grand R (2014) Protective effect of vaginal application of neutralizing and nonneutralizing inhibitory antibodies against vaginal SHIV challenge in macaques. Mucosal Immunol 7(1):46-56. doi:10.1038/mi.2013.23
93. Naziruddin B, Duffy BF, Tucker J, Mohanakumar T (1992) Evidence for cross-regulation of Fc gamma RIIIB (CD16) receptor-mediated signaling by Fc gamma RII (CD32) expressed on polymorphonuclear neutrophils. J Immunol 149(11):3702-3709
94. Nguyen D, Sanghvi R, Scinicariello F, Pulit-Penaloza J, Hill N, Attanasio R (2014) Cynomolgus and pigtail macaque IgG subclasses: characterization of IGHG genes and computational analysis of IgG/Fc receptor binding affinity. Immunogenetics 66(6):361-377. doi:10.1007/ s00251-014-0775-4
95. Nguyen D, Scinicariello F, Attanasio R (2011) Characterization and allelic polymorphisms of rhesus macaque (Macaca mulatta) IgG Fc receptor genes. Immunogenetics 63(6):351-362. doi:10.1007/s00251-011-0514-z
96. Peressin M, Proust A, Schmidt S, Su B, Lambotin M, Biedma ME, Laumond G, Decoville T, Holl V, MoogC(2014) Efficient transfer of HIV-1 in trans and in cis from Langerhans dendritic cells and macrophages to autologous T lymphocytes. Aids. doi:10.1097/QAD.0000000000000193
97. Perez LG, Costa MR, Todd CA, Haynes BF, Montefiori DC (2009) Utilization of immunoglobulin G Fc receptors by human immunodeficiency virus type 1: a specific role for antibodies against the membrane-proximal external region of gp41. J Virol 83(15):7397-7410. doi:10. 1128/JVI.00656-09
98. Pietersz GA, Mottram PL, van de Velde NC, Sardjono CT, Esparon S, Ramsland PA, Moloney G, Baell JB, McCarthy TD, Matthews BR, Powell MS, Hogarth PM (2009) Inhibition of destructive autoimmune arthritis in FcgammaRIIa transgenic mice by small chemical entities. Immunol Cell Biol 87(1):3-12
99. Powell MS, Barnes NC, Bradford TM, Musgrave IF, Wines BD, Cambier JC, Hogarth PM (2006) Alteration of the Fc gamma RIIa dimer interface affects receptor signaling but not ligand binding. J Immunol 176(12):7489-7494
100. Powell MS, Barton PA, Emmanouilidis D, Wines BD, Neumann GM, Peitersz GA, Maxwell KF, Garrett TPJ, Hogarth PM (1999) Biochemical analysis and crystallisation of FcγRIIa, the low affinity receptor for IgG. Immunol Lett 68(1):17-23
101. Radaev S, Motyka S, Fridman W-H, Sautes-Fridman C, Sun PD (2001) The structure of a human type III Fcc receptor in complex with Fc. J Biol Chem 276(19):16469-16477. doi:10.1074/ jbc.M100350200
102. Ramsland PA, Farrugia W, Bradford TM, Sardjono CT, Esparon S, Trist HM, Powell MS, Tan PS, Cendron AC, Wines BD, Scott AM, Hogarth PM (2011) Structural basis for Fc gammaRIIa recognition of human IgG and formation of inflammatory signaling complexes. J Immunol 187(6):3208-3217
103. Ravetch J (2010) In vivo veritas: the surprising roles of Fc receptors in immunity. Nat Immunol 11(3):183-185. doi:10.1038/ni0310-183
104. Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, Paris R, Premsri N, Namwat C, de Souza M, Adams E, Benenson M, Gurunathan S, Tartaglia J, McNeil JG, Francis DP, Stablein D, Birx DL, Chunsuttiwat S, Khamboonruang C, Thongcharoen P, Robb ML, Michael NL, Kunasol P, Kim JH (2009) Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. New Engl J Med 361(23):2209-2220
105. Rispens T, Davies AM, Ooijevaar-de Heer P, Absalah S, Bende O, Sutton BJ, Vidarsson G, Aalberse RC (2014) Dynamics of inter-heavy chain interactions in human immunoglobulin G (IgG) subclasses studied by kinetic Fab arm exchange. J Biol Chem 289(9):6098-6109. doi:10.1074/jbc.M113.541813
106. Rogers KA, Scinicariello F, Attanasio R (2006) IgG Fc receptor III homologues in nonhuman primate species: genetic characterization and ligand interactions. J Immunol 177(6):3848-3856
107. Sallusto F, Lanzavecchia A (1994) Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 179(4):1109-1118
108. Scharf O, Golding H, King LR, Eller N, Frazier D, Golding B, Scott DE
109. Scinicariello F, Engleman CN, Jayashankar L, McClure HM, Attanasio R (2004) Rhesus macaque antibody molecules: sequences and heterogeneity of alpha and gamma constant regions. Immunology 111(1):66-74. doi:10.1111/j.1365-2567. 2004.01767.x
110. Shields RL, Lai J, Keck R, O'Connell LY, Hong K, Meng YG, Weikert SH, Presta LG (2002) Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity. J Biol Chem 277(30):26733-26740. doi:10.1074/jbc.M202069200
111. Shields RL, Namenuk AK, Hong K, Meng YG, Rae J, Briggs J, Xie D, Lai J, Stadlen A, Li B, Fox JA, Presta LG (2001) High resolution mapping of the binding site on human IgG1 for FcγRI, FcγRII, FcγRIII, and FcRn and design of IgG1 variants with improved binding to the FcγR. J Biol Chem 276(9):6591-6604. doi:10.1074/jbc.M009483200
112. Sole-Violan J, Garcia-Laorden MI, Marcos-Ramos JA, Rodriguez de Castro F, Rajas O, Borderias L, Briones ML, Herrera-Ramos E, Blanquer J, Aspa J, Florido Y, Garcia-Bello MA, Ferrer-Aguero JM, Sologuren I, Rodriguez-Gallego C (2011) The Fc[gamma] receptor IIA-H/ H131 genotype is associated with bacteremia in pneumococcal community-acquired pneumonia. Crit Care Med 39(6):1388-1393
113. Sondermann P, Huber R, Oosthuizen V, Jacob U (2000) The 3.2-A crystal structure of the human IgG1 Fc fragment-Fcbig gammaRIII complex. Nature 406:267-273
114. Starbeck-Miller GR, Badovinac VP, Barber DL, Harty JT (2014) Cutting edge: expression of FcγRIIB tempers memory CD8 T cell function in vivo. J Immunol 192(1):35-39. doi:10. 4049/jimmunol.1302232
115. Takai T (2005) Fc receptors and their role in immune regulation and autoimmunity. J Clin Immunol 25(1):1-18. doi:10.1007/s10875-005-0353-8
116. Tan Sardjono C, Mottram PL, Hogarth PM (2003) The role of FcgammaRIIa as an inflammatory mediator in rheumatoid arthritis and systemic lupus erythematosus. Immunol Cell Biol 81(5):374-381
117. Tan Sardjono C, Mottram PL, van de Velde NC, Powell MS, Power D, Slocombe RF, Wicks IP, Campbell IK, McKenzie SE, Brooks M, Stevenson AW, Hogarth PM (2005) Development of spontaneous multisystem autoimmune disease and hypersensitivity to antibody-induced inflammation in Fcgamma receptor IIa-transgenic mice. Arthritis Rheum 52(10):3220-3229
118. Tate BJ, Witort E, McKenzie IFC, Hogarth PM (1992) Expression of the high responder/ non-responder human Fcbig gammaRII. Analysis by PCR and transfection into FcR COS cells. Immunol Cell Biol 70:79-87
119. Trist HM, Tan PS, Wines BD, Ramsland PA, Orlowski E, Stubbs J, Gardiner EE, Pietersz GA, Kent SJ, Stratov I, Burton DR, Hogarth PM (2014) Polymorphisms and interspecies differences of the activating and inhibitory FcγRII of Macaca nemestrina influence the binding of human IgG subclasses. J Immunol 192(2):792-803. doi:10.4049/jimmunol. 1301554
120. Tse WY, Abadeh S, Jefferis R, Savage CO, Adu D (2000) Neutrophil FcgammaRIIIb allelic polymorphism in anti-neutrophil cytoplasmic antibody (ANCA)-positive systemic vasculitis. Clin Exp Immunol 119(3):574-577
121. van der Heijden J, Breunis WB, Geissler J, de Boer M, van den Berg TK, Kuijpers TW (2012) Phenotypic variation in IgG receptors by nonclassical FCGR2C alleles. J Immunol 188(3):1318-1324. doi:10.4049/jimmunol.1003945
122. van der Neut Kolfschoten M, Schuurman J, Losen M, Bleeker WK, Martínez-Martínez P, Vermeulen E, den Bleker TH, Wiegman L, Vink T, Aarden LA, De Baets MH, van de Winkel JGJ, Aalberse RC, Parren PWHI (2007) Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange. Science 317(5844):1554-1557. doi:10.1126/science.1144603
123. van Sorge NM, van der Pol WL, Jansen MD, Geleijns KP, Kalmijn S, Hughes RA, Rees JH, Pritchard J, Vedeler CA, Myhr KM, Shaw C, van Schaik IN, Wokke JH, van Doorn PA, Jacobs BC, van de Winkel JG, van den Berg LH (2005) Severity of Guillain-Barre syndrome is associated with Fc gamma receptor III polymorphisms. J Neuroimmunol 162(1-2):157-164. doi:10.1016/j.jneuroim.2005.01.016
124. van Sorge NM, van Der Pol WL, van De Winkel JGJ (2003) FcγR polymorphisms: implications for function, disease susceptibility and immunotherapy. Tissue Antigens 61(3):189-202. doi:10.1034/j.1399-0039.2003. 00037.x
125. Waltz E (2012) HIV neutralizing antibodies reignite interest in vaccine. Nat Biotechnol 30(3):204-205
126. Warncke M, Calzascia T, Coulot M, Balke N, Touil R, Koblinger F, Heusser C (2012) Different adaptations of IgG effector function in human and nonhuman primates and implications for therapeutic antibody treatment. J Immunol 188:4405-4411
127. Warnerdanm OAM, van de Winkel JGJ, Gosselin EJ, Capel PJA (1990) Molecular basis for a polymorphism of human Fc gamma receptor II (CD32). J Exp Med 172(1):19-25
128. Waterman PM, Cambier JC (2010) The conundrum of inhibitory signaling by ITAM-containing immunoreceptors: potential molecular mechanisms. FEBS Lett 584(24):4878-4882. doi:10. 1016/j.febslet.2010.09.029
129. Webster RL, Johnson RP (2005) Delineation of multiple subpopulations of natural killer cells in rhesus macaques. Immunology 115(2):206-214. doi:10.1111/j.1365-2567.2005.02147.x
130. Weng W-K, Levy R (2003) Two immunoglobulin G fragment C receptor polymorphisms independently predict response to Rituximab in patients with follicular lymphoma. J Clin Oncol 21(21):3940-3947. doi:10.1200/jco.2003.05.013
131. Willcocks LC, Lyons PA, Clatworthy MR, Robinson JI, Yang W, Newland SA, Plagnol V, McGovern NN, Condliffe AM, Chilvers ER, Adu D, Jolly EC, Watts R, Lau YL, Morgan AW, Nash G, Smith KG (2008) Copy number of FCGR3B, which is associated with systemic lupus erythematosus, correlates with protein expression and immune complex uptake. J Exp Med 205(7):1573-1582. doi:10.1084/jem.20072413
132. Wren LH, Chung AW, Isitman G, Kelleher AD, Parsons MS, Amin J, Cooper DA, Investigators Asc, Stratov I, Navis M, Kent SJ (2012) Specific antibody-dependent cellular cytotoxicity responses associated with slow progression of HIV infection. Immunology 138(2):116-123. doi:10.1111/imm.12016